Skip to main content
logo
Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam flag Vietnam · Delayed Price · Currency is VND
60,300
-300 (-0.50%)
At close: Nov 3, 2026

HNX:DP3 Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Net Income
215,999156,073121,172125,263108,82494,305
Depreciation & Amortization
21,04812,40112,94113,980--
Other Amortization
14080----
Loss (Gain) From Sale of Assets
-22,864-22,864-15,492-21,684--
Other Operating Activities
-105,3035,366-1,0414,079-9,609-67,997
Change in Accounts Receivable
-3,296-3,296-24,07613,163--
Change in Inventory
-12,741-12,7418,40617,504--
Change in Accounts Payable
17,04117,041-10,859-414.91--
Change in Other Net Operating Assets
-553.55-553.55866.971,211--
Operating Cash Flow
109,470151,50791,917153,10299,21526,308
Operating Cash Flow Growth
-46.01%64.83%-39.96%54.31%277.13%-78.50%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Capital Expenditures
-7,588-7,588-1,465-6,403-15,089-446.26
Sale of Property, Plant & Equipment
3030269.411,824--
Other Investing Activities
24,67019,99416,85217,5218,8146,324
Investing Cash Flow
-93,482-130,566-11,330-102,680-54,65425,878

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Short-Term Debt Issued
----15,41410,210
Long-Term Debt Issued
-91,17210,10015,110--
Total Debt Issued
91,17291,17210,10015,11015,41410,210
Short-Term Debt Repaid
-----12,222-12,060
Long-Term Debt Repaid
--56,899-17,875-12,565-1,490-
Total Debt Repaid
-103,212-56,899-17,875-12,565-13,712-12,060
Net Debt Issued (Repaid)
-12,04034,273-7,7752,5451,702-1,850
Common Dividends Paid
-2,249-64,444-64,481-68,698-49,885-66,529
Financing Cash Flow
-14,289-30,171-72,256-66,153-48,183-68,379

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.910.050.270.7225.842.48
Net Cash Flow
1,698-9,2318,331-15,731-3,596-16,191

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Free Cash Flow
101,882143,91990,452146,69984,12625,862
Free Cash Flow Growth
-49.39%59.11%-38.34%74.38%225.29%-52.21%
Free Cash Flow Margin
19.43%32.86%21.67%35.80%17.34%6.79%
Free Cash Flow Per Share
4738.706693.914207.106823.213717.111202.91
Levered Free Cash Flow
110,641112,87777,061127,65060,23055,727
Unlevered Free Cash Flow
111,818113,31177,162128,64664,27756,008

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Cash Interest Paid
1,890679.56188.51,5672,8681,207
Cash Income Tax Paid
36,11531,17931,74027,66524,15929,399
Change in Working Capital
450.61450.61-25,66231,463--